Segment and Geographic Information (Notes)

12 Months Ended

Dec. 31, 2013

Segment Reporting [Abstract]

Reporting Segments

The structure of the Company’s internal organization is divided into the following reportable segments, which are also the Company's operating segments: Energy & Chemicals (“E&C”), Distribution & Storage (“D&S”) and BioMedical. The Company’s reportable segments are business units that are each managed separately because they manufacture, offer and distribute distinct products with different production processes and sales and marketing approaches. The E&C segment sells brazed aluminum and air-cooled heat exchangers and cold boxes to natural gas, petrochemical processing and industrial gas companies who use them for the liquefaction and separation of natural and industrial gases. The D&S segment sells cryogenic bulk storage systems, cryogenic packaged gas systems, cryogenic systems and components, beverage liquid CO₂ systems, cryogenic flow meter systems and cryogenic services to various companies for the storage and transportation of both industrial and natural gases. The BioMedical segment sells medical respiratory products, biological storage systems and other oxygen products. Due to the nature of the products that each segment sells, there are no intersegment sales. Corporate includes operating expenses for executive management, accounting, tax, treasury, development, human resources, information technology, investor relations, legal, internal audit, risk management and share-based compensation expenses that are not allocated to the reporting segments.

The Company evaluates performance and allocates resources based on operating income or loss from continuing operations before interest expense, net, amortization of deferred financing costs, foreign currency gain (loss), income taxes and noncontrolling interests. The accounting policies of the reportable segments are the same as those described in Note 2.

Segment Financial Information

	Year Ended December 31, 2013
	Energy & Chemicals		Distribution & Storage		BioMedical		Corporate			Total
Sales to external customers	$	318,510	$	592,616	$	266,312	$	—		$	1,177,438
Depreciation and amortization expense	8,564		15,237		14,618		1,970			40,389
Operating income (loss)	59,671		93,560		33,039		(50,273		)	135,997
Total assets (1)	277,760		676,484		431,763		75,623			1,461,630
Capital expenditures	34,194		32,039		3,370		2,982			72,585

	Year Ended December 31, 2012
	Energy & Chemicals		Distribution & Storage		BioMedical		Corporate			Total
Sales to external customers	$	323,676	$	475,576	$	214,900	$	—		$	1,014,152
Depreciation and amortization expense	7,877		12,599		10,204		1,516			32,196
Operating income (loss)	64,931		79,175		24,079		(46,372		)	121,813
Total assets (1)	203,044		607,252		447,792		69,753			1,327,841
Capital expenditures	9,519		30,048		2,717		1,401			43,685

	Year Ended December 31, 2011
	Energy & Chemicals		Distribution & Storage		BioMedical		Corporate			Total
Sales to external customers	$	205,033	$	390,332	$	199,220	$	—		$	794,585
Depreciation and amortization expense	7,417		11,767		7,588		1,143			27,915
Operating income (loss)	27,489		61,415		35,911		(34,821		)	89,994
Total assets (1)	203,067		556,688		226,729		187,991			1,174,475
Capital expenditures	5,228		7,808		6,692		2,652			22,380

_______________

⁽¹⁾  Corporate assets consist primarily of cash, cash equivalents and deferred income taxes.

The following table represents the changes in goodwill by segment:

	Energy & Chemicals		Distribution & Storage		BioMedical			Total
Balance at January 1, 2012	$	83,215	$	158,381	$	47,174		$	288,770
Foreign currency translation adjustments and other	—		408		—			408
Goodwill acquired during the year	—		—		109,763			109,763
Balance at December 31, 2012	83,215		158,789		156,937			398,941
Foreign currency translation adjustments and other	—		957		(1,301		)	(344		)
Goodwill acquired during the year	—		308		—			308
Balance at December 31, 2013	$	83,215	$	160,054	$	155,636		$	398,905

Product Sales Information

	Year Ended December 31,
	2013		2012		2011
Energy & Chemicals
Heat exchangers – Brazed aluminum	$	170,104	$	146,110	$	92,013
Heat exchangers – Air cooled	54,275		69,977		66,962
Cold boxes	94,131		107,589		46,058
Energy & Chemicals Total	318,510		323,676		205,033
Distribution & Storage
Cryogenic bulk storage systems	175,123		153,372		153,518
Cryogenic packaged gas systems and beverage liquid CO2 systems	152,922		143,548		142,262
LNG applications	193,032		107,231		35,678
Cryogenic systems, components and services	71,539		71,425		58,874
Distribution & Storage Total	592,616		475,576		390,332
BioMedical
Medical respiratory products	175,233		143,878		138,411
Biological storage systems	61,493		64,449		60,809
On-site oxygen generation systems	29,586		6,573		—
BioMedical Total	266,312		214,900		199,220
Total	$	1,177,438	$	1,014,152	$	794,585

Geographic Information

Net sales by geographic area are reported by the destination of sales. Net property, plant and equipment by geographic area are reported by country of domicile.

	Sales for the Year Ended December 31,
	2013		2012		2011
United States	$	479,067	$	438,294	$	334,517
China	231,143		149,010		92,142
Rest of World	467,228		426,848		367,926
Total	$	1,177,438	$	1,014,152	$	794,585

	Property, plant and equipment, net as of December 31,
	2013		2012		2011
United States	$	146,610	$	98,425	$	75,848
Czech Republic	23,623		21,559		21,805
China	38,569		34,158		23,410
Germany	14,618		14,402		14,672
Other foreign countries	785		1,232		1,566
Total	$	224,205	$	169,776	$	137,301